Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Report on the European Conference on Septic Shock of the European Society of Intensive Care Medicine and the European Shock Society, Brussels, Belgium, March 1-2, 1987.

Literature DB >> 2897983

Report on the European Conference on Septic Shock of the European Society of Intensive Care Medicine and the European Shock Society, Brussels, Belgium, March 1-2, 1987.

I M Ledingham¹, K Messmer, L Thijs.

Abstract

Entities: Gene

Mesh：

Year: 1988 PMID： 2897983 DOI： 10.1007/bf00717984

Source DB: PubMed Journal: Intensive Care Med ISSN： 0342-4642 Impact factor: 17.440

× No keyword cloud information.

13 in total

1. A controlled clinical trial of high-dose methylprednisolone in the treatment of severe sepsis and septic shock.

Authors: R C Bone; C J Fisher; T P Clemmer; G J Slotman; C A Metz; R A Balk
Journal: N Engl J Med Date: 1987-09-10 Impact factor: 91.245

Review 2. Triple regimen of selective decontamination of the digestive tract, systemic cefotaxime, and microbiological surveillance for prevention of acquired infection in intensive care.

Authors: I M Ledingham; S R Alcock; A T Eastaway; J C McDonald; I C McKay; G Ramsay
Journal: Lancet Date: 1988-04-09 Impact factor: 79.321

3. Prevention of gram-negative shock and death in surgical patients by antibody to endotoxin core glycolipid.

Authors: J D Baumgartner; M P Glauser; J A McCutchan; E J Ziegler; G van Melle; M R Klauber; M Vogt; E Muehlen; R Luethy; R Chiolero
Journal: Lancet Date: 1985-07-13 Impact factor: 79.321

4. Prevention of colonization and respiratory infections in long-term ventilated patients by local antimicrobial prophylaxis.

Authors: K Unertl; G Ruckdeschel; H K Selbmann; U Jensen; H Forst; F P Lenhart; K Peter
Journal: Intensive Care Med Date: 1987 Impact factor: 17.440

5. Cryoprecipitate infusion fails to improve organ function in septic shock.

Authors: F Hesselvik; B Brodin; C Carlsson; B Cedergren; L Jorfeldt; G Liedén
Journal: Crit Care Med Date: 1987-05 Impact factor: 7.598

6. Coronary hemodynamics and myocardial metabolism of lactate, free fatty acids, glucose, and ketones in patients with septic shock.

Authors: J F Dhainaut; M F Huyghebaert; J F Monsallier; G Lefevre; J Dall'Ava-Santucci; F Brunet; D Villemant; A Carli; D Raichvarg
Journal: Circulation Date: 1987-03 Impact factor: 29.690

Report on the European Conference on Septic Shock of the European Society of Intensive Care Medicine and the European Shock Society, Brussels, Belgium, March 1-2, 1987.

1. A controlled clinical trial of high-dose methylprednisolone in the treatment of severe sepsis and septic shock.

Review 2. Triple regimen of selective decontamination of the digestive tract, systemic cefotaxime, and microbiological surveillance for prevention of acquired infection in intensive care.

3. Prevention of gram-negative shock and death in surgical patients by antibody to endotoxin core glycolipid.

4. Prevention of colonization and respiratory infections in long-term ventilated patients by local antimicrobial prophylaxis.

5. Cryoprecipitate infusion fails to improve organ function in septic shock.

6. Coronary hemodynamics and myocardial metabolism of lactate, free fatty acids, glucose, and ketones in patients with septic shock.

7. Effect of high-dose glucocorticoid therapy on mortality in patients with clinical signs of systemic sepsis.

8. Hemodynamic determinants of mortality in human septic shock.

9. The coronary circulation in human septic shock.

10. Treatment of gram-negative bacteremia and shock with human antiserum to a mutant Escherichia coli.

1. An assessment of plasma histamine concentrations during documented endotoxic shock.